Filling the need for trusted information on national health issues

FT Health Discusses Topics Addressed At WHA, Features Interview With Takeda Pharmaceutical CEO

FT Health: U.S. support for global health comes at a price
The latest issue of the Financial Times’ weekly global health newsletter highlights topics discussed at the 71st World Health Assembly, including the WHO director general’s call for “fresh funding and partnerships” and the U.S. stance on global health security. The newsletter also features an interview with Christophe Weber, CEO of Takeda Pharmaceutical, on acquiring Shire, which specializes in rare diseases, and provides a round-up of global health-related news stories (Jack et al., 5/25).